Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6620)
All Articles published online
|
Publishing Process of This Article
|
Dec 10, 2016 (publication date) through May 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Van Der Steen N, Deben C, Deschoolmeester V, Wouters A, Lardon F, Rolfo C, Germonpré P, Giovannetti E, Peters GJ, Pauwels P. Better to be alone than in bad company: The antagonistic effect of cisplatin and crizotinib combination therapy in non-small cell lung cancer. World J Clin Oncol 2016; 7(6): 425-432 [PMID: 28008383 DOI: 10.5306/wjco.v7.i6.425] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v7/i6/425.htm |
| Number | Citing Articles |
| 1 |
Somayeh Nazari, Fatemeh Mosaffa, Alireza Poustforoosh, Motahareh Mortazavi, Luciano Saso, Omidreza Firuzi, Fatemeh Moosavi. Foretinib, a c-MET receptor tyrosine kinase inhibitor, tackles multidrug resistance in cancer cells by inhibiting ABCB1 and ABCG2 transporters. Toxicology and Applied Pharmacology 2024; 484: 116866 doi: 10.1016/j.taap.2024.116866
|
| 2 |
Vincent Chin-Hung Chen, Shao-Lan Huang, Jing-Yu Huang, Tsai-Ching Hsu, Bor-Show Tzang, Roger S. McIntyre. Combined Administration of Escitalopram Oxalate and Nivolumab Exhibits Synergistic Growth-Inhibitory Effects on Liver Cancer Cells through Inducing Apoptosis. International Journal of Molecular Sciences 2023; 24(16): 12630 doi: 10.3390/ijms241612630
|
| 3 |
Nehad M. Ayoub, Dalia R. Ibrahim, Amer E. Alkhalifa, Belal A. Al-Husein. Crizotinib induced antitumor activity and synergized with chemotherapy and hormonal drugs in breast cancer cells via downregulating MET and estrogen receptor levels. Investigational New Drugs 2021; 39(1): 77 doi: 10.1007/s10637-020-00989-0
|
| 4 |
Fatemeh Moosavi, Elisa Giovannetti, Godefridus J. Peters, Omidreza Firuzi. Combination of HGF/MET-targeting agents and other therapeutic strategies in cancer. Critical Reviews in Oncology/Hematology 2021; 160: 103234 doi: 10.1016/j.critrevonc.2021.103234
|
| 5 |
Grzegorz Szparecki, T. Ilczuk, N. Gabzdyl, E. Stocka-Łabno, B. Górnicka. Expression of c-MET Protein in Various Subtypes of Hepatocellular Adenoma Compared to Hepatocellular Carcinoma and Non-Neoplastic Liver in Human Tissue. Folia Biologica 2017; 63(4): 146 doi: 10.14712/fb2017063040146
|
| 6 |
Tahereh Damghani, Fatemeh Moosavi, Mehdi Khoshneviszadeh, Motahareh Mortazavi, Somayeh Pirhadi, Zahra Kayani, Luciano Saso, Najmeh Edraki, Omidreza Firuzi. Imidazopyridine hydrazone derivatives exert antiproliferative effect on lung and pancreatic cancer cells and potentially inhibit receptor tyrosine kinases including c-Met. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-83069-4
|